Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses
Clinical trial NCT04646980 · COMPLETED
Trial details
- NCT number
- NCT04646980
- Sponsor
- Zagazig University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-28
- Primary completion
- 2019-02-28
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.